Kena A. Swanson
Pfizer (United States)(US)Pfizer (United Kingdom)(GB)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, Viral gastroenteritis research and epidemiology, Animal Virus Infections Studies, Pneumonia and Respiratory Infections
Most-Cited Works
- → Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine(2020)15,281 cited
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses(2020)2,020 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,576 cited
- → Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents(2021)921 cited
- → Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants(2023)874 cited
- → BNT162b vaccines protect rhesus macaques from SARS-CoV-2(2021)731 cited
- → Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera(2021)672 cited
- → Neutralizing Activity of BNT162b2-Elicited Serum(2021)631 cited
- → Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age(2021)616 cited